- Featured News /
The RUXCOVID clinical trial highlights the Novartis commitment to leverage our expertise and resources to support the global response to the COVID-19 pandemic.
- Featured News /
NIBR translational immunologists and academic colleagues observe two distinct molecular patterns of disease progression in lung tissue samples.
- Featured News /
To celebrate International Women’s Day we explore how an inclusive environment that values unique and curious minds helps everyone be inspired to innovate every day.
- Featured News /
Latest resources and news surrounding Novartis data featured at the 63nd American Society of Hematology Annual Meeting (ASH).
- Featured News /
Novartis Chief Digital Officer, Bertrand Bodson, and Microsoft Corporate Vice President Research & Incubation, Peter Lee, discussed why healthcare’s digital moment is now.
- Featured News /
Standing by people with sickle cell disease and their families
- Featured News /
Latest oncology resources and news surrounding Novartis data featured at American Society of Clinical Oncology (ASCO)
- Featured News /
As a company, we stand up for greater inclusion of LGBTI people because when each of us feels included, we all benefit.
- Statement /
Novartis condemns the war in Ukraine and has been providing humanitarian support, financial donations as well as considerable volumes of medicines to those people impacted by the war.
- Featured News /
Novartis is committed to reimagining the fight against Chagas Disease and advocating for an integrated, end-to-end care approach.
Pagination
- ‹ Previous page
- 1
- …
- 100
- 101
- 102
- 103
- 104
- 105
- 106
- …
- 277
- › Next page